China 's gene therapy market is predicted to grow from CNY7.2bn ( $ 1.06bn ) last year to CNY18.3bn by 2022 , thanks to increased investment from equipment makers and increased export income , according to Beijing - based CCID Consulting . The international market is currently worth $ 3bn , but Global Market Insights predicted it to expand to $ 22bn by 2020 . It is good news for firms such as Tencent - backed Centrillion , which has developed third - generation DNA - based semiconductor chips . It has two plants based in China and harbours hopes of achieving annual revenues of $ 5000 .
China's gene sequencing market is predicted to grow from CNY7.2bn ($1.06bn) last year to CNY18.3bn by 2022, thanks to increased investment from equipment makers and rising consumer income, according to Beijing-based CCID Consulting. The international market is currently worth $3bn, but Global Market Insights predicted it will expand to $22bn by 2024. It is good news for firms such as Tencent-backed Centrillion, which has developed third-generation DNA-sequencing semiconductor chips. It has two plants based in China and harbours ambitions of achieving annual revenues of $1bn.